Daniel Couto

Mr. Couto has 25 years of experience in biotechnology, biologics drug development and cGMP manufacturing, including at Merck Sharp Dohme Biologics UK (formerly Avecia Biologics), where he served as Vice President of Commercial Manufacturing Operations and was responsible for late stage and commercial manufacturing operations. In addition, Mr. Couto has held senior positions with several biotech companies including Nuvelo, Genzyme Transgenics and Advanced Biosystems and, most recently, was Senior Vice President of Manufacturing and Facilities Operations at ContraFect Corporation where he was responsible for chemistry & manufacturing controls, supply chain, quality assurance and facilities.

Mr. Couto holds multiple U.S. patents. He received his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.